NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM724265 Query DataSets for GSM724265
Status Public on Aug 19, 2012
Title prePatient9-2
Sample type RNA
 
Channel 1
Source name non tumor lesion of liver biopsy, pre peretinoin administration
Organism Homo sapiens
Characteristics patient: 9-2
tissue: non tumor lesion of liver biopsy
agent: none
time: control
Treatment protocol Peretinoin, a member of the acyclic retinoid family, is expected to be an effective chemo preventive drug for HCC.The patients had undergone curative surgical resection or radiofrequency ablation (RFA). They received 300 mg/day or 600 mg/day of peretinoin for 8 weeks and were followed up for 88 weeks with 600 mg/day of peretinoin. Hepatic gene expression profiling obtained from non tumor lesion of these patients prior to administering peretinoin and 8 weeks after starting peretinoin treatment
Extracted molecule total RNA
Extraction protocol Total RNA was isolated from liver biopsy samples using an RNA extraction kit (Micro RNA Extraction Kit, Stratagene, La Jolla, CA, USA). Aliquots of total RNA (5 ug) were subjected to amplification with antisense RNA (aRNA) using a Message AmpTM aRNA kit (Ambion, Austin, TX, USA) as recommended by the manufacturer
Label Cy5
Label protocol As a reference for each microarray analysis, aRNA samples prepared from the normal liver tissue from one of the patients were used. Test RNA samples fluorescently labeled with cyanine (Cy) 5 and reference RNA labeled with Cy3 were used for microarray hybridization
 
Channel 2
Source name normal liver sample from a patient [reference]
Organism Homo sapiens
Characteristics tissue: normal liver
Treatment protocol Peretinoin, a member of the acyclic retinoid family, is expected to be an effective chemo preventive drug for HCC.The patients had undergone curative surgical resection or radiofrequency ablation (RFA). They received 300 mg/day or 600 mg/day of peretinoin for 8 weeks and were followed up for 88 weeks with 600 mg/day of peretinoin. Hepatic gene expression profiling obtained from non tumor lesion of these patients prior to administering peretinoin and 8 weeks after starting peretinoin treatment
Extracted molecule total RNA
Extraction protocol Total RNA was isolated from liver biopsy samples using an RNA extraction kit (Micro RNA Extraction Kit, Stratagene, La Jolla, CA, USA). Aliquots of total RNA (5 ug) were subjected to amplification with antisense RNA (aRNA) using a Message AmpTM aRNA kit (Ambion, Austin, TX, USA) as recommended by the manufacturer
Label Cy3
Label protocol As a reference for each microarray analysis, aRNA samples prepared from the normal liver tissue from one of the patients were used. Test RNA samples fluorescently labeled with cyanine (Cy) 5 and reference RNA labeled with Cy3 were used for microarray hybridization
 
 
Hybridization protocol Reference papers; Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Kaneko S. Hepatology. 2006 Nov;44(5):1122-38, Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Gastroenterology. 2001 Mar;120(4):955-66.
Scan protocol Quantitative assessment of the signals on the slides was carried out by scanning on a ScanArray 5000 (General Scanning, Watertown, MA, USA) followed by image analysis using GenePix Pro 4.1(Axon Instruments, Union City, CA, USA)
Description 600mgnonRecurrence
Data processing Because the levels of expression of some housekeeping genes were also changed, especially in advanced stages of liver disease, for the normalization of data we averaged intensities of all spots obtained with Cy3 and Cy5 in each of the 16 rectangles and adjusted intensity of each corrected DNA spot as the average intensity ratio Cy5/Cy3 = 1.0. This global normalization of intensity provided smaller variance of CyS/Cy3 ratio and almost equivalent results to normalization using the housekeeping genes.
Reference papers; Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Kaneko S. Hepatology. 2006 Nov;44(5):1122-38, Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Gastroenterology. 2001 Mar;120(4):955-66.
 
Submission date May 15, 2011
Last update date Aug 19, 2012
Contact name Masao Honda
E-mail(s) mhondag@gmail.com
Phone 0762652243
Organization name Kanazawa University
Department Gastroenterology
Street address Takara-Machi 13-1
City Kanazawa
ZIP/Postal code 920-8641
Country Japan
 
Platform ID GPL13536
Series (1)
GSE29302 Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development

Data table header descriptions
ID_REF
VALUE log2 of PRE_VALUE; normalized log2 ratio (Cy5/Cy3) representing test/reference
PRE_VALUE normalized ratio (Cy5/Cy3) representing test/reference

Data table
ID_REF VALUE PRE_VALUE
1001 -0.0163 0.988738296
1002 -0.1328 0.912050899
1003 -0.1820 0.881487977
1004 -0.5613 0.677671885
1005 0.0002 1.000141738
1006 0.3067 1.236907881
1007 0.1844 1.136344883
1008 -0.7647 0.588594739
1009 -0.9384 0.521826634
1010 -0.0729 0.950724122
1011 -0.0418 0.971453728
1012 0.6543 1.573860818
1013 -0.3718 0.772802701
1014 0.5912 1.506463718
1015 -0.1259 0.916437743
1016 0.3567 1.28051152
1017 0.1306 1.094752993
1018 -1.2059 0.433510476
1019 0.2396 1.180624555
1020 -0.0167 0.988473916

Total number of rows: 9643

Table truncated, full table size 227 Kbytes.




Supplementary file Size Download File type/resource
GSM724265_11n2.gpr.gz 918.9 Kb (ftp)(http) GPR
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap